Medicine
Procainamide 1000 mg/10 mL injection
Procainamide 1000 mg/10 mL injection is a generic prescription medicine for intramuscular, intravenous use, made by 10 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20˚ to 25˚C (68˚ to 77˚F).
Key facts
- Active ingredient (INN)
- Procainamide
- Brand
- Sold under the generic name
- Strength
- 1000 mg/10 mL
- Dosage form
- Injection
- Route
- Intramuscular, intravenous
- Packs
- 10 vials of 10 mL, 25 cartons of 10 mL, 5 syringes of 10 mL and 10 more
- Manufacturers
- Caplin SterilesIndiaGland PharmaIndiaHealthFirstMedical Purchasing SolutionsHospiraInternational Medication SystemsNexus PharmaceuticalsProPharma DistributionRemedyrepackSagent Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Store at 20˚ to 25˚C (68˚ to 77˚F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- C01BA02 Procainamide
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 8 March 2006
- Identifiers
- RxCUI 1862220, 857886, 857962DailyMed set ID 3d5d9d6e-1f1c-7565-e063-6394a90a93e7, fece65c0-fdbc-61d8-e053-6294a90a9a68, 8192d79d-da2b-2532-e053-2991aa0ae8ad +9NDC 84549-399, 51662-1630, 51662-1334 +9Application ANDA088636, ANDA089069, ANDA218135 +2
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 10 vial, multi-dose in 1 carton / 10 mL in 1 vial, multi-dose | 65145-155-10 | Caplin SterilesIndia | 17 February 2025 |
| 25 carton in 1 case / 1 vial, multi-dose in 1 carton / 10 mL in 1 vial, multi-dose | 68083-603-25 | Gland PharmaIndia | 22 July 2024 |
| 25 carton in 1 case / 1 vial, multi-dose in 1 carton / 10 mL in 1 vial, multi-dose | 0409-1902-01 | Hospira | 8 March 2006 |
| 5 syringe in 1 package / 10 mL in 1 syringe | 76329-3399-5 | International Medication Systems | 21 December 2016 |
| 10 vial, multi-dose in 1 carton / 10 mL in 1 vial, multi-dose | 14789-901-10 | Nexus Pharmaceuticals | 14 October 2007 |
| 10 vial in 1 carton / 10 mL in 1 vial | 25021-322-10 | Sagent Pharmaceuticals | 15 January 2025 |
| 1 vial, multi-dose in 1 carton / 10 mL in 1 vial, multi-dose | 51662-1334-1 | HealthFirst | 10 February 2019 |
| 25 pouch in 1 box / 1 vial, multi-dose in 1 pouch / 10 mL in 1 vial, multi-dose | 51662-1334-3 | HealthFirst | 15 March 2022 |
| 5 pouch in 1 case / 1 box in 1 pouch / 1 syringe in 1 box / 10 mL in 1 syringe | 51662-1630-3 | HealthFirst | 23 June 2023 |
| 1 carton in 1 bag / 1 vial, multi-dose in 1 carton / 10 mL in 1 vial, multi-dose | 71872-7113-1 | Medical Purchasing Solutions | 12 September 2023 |
| 1 vial in 1 bag / 10 mL in 1 vial | 71872-7353-1 | Medical Purchasing Solutions | 28 May 2025 |
| 10 mL in 1 syringe | 84549-399-05 | ProPharma Distribution | 1 September 2025 |
| 5 syringe in 1 package / 10 mL in 1 syringe | 70518-4208-0 | Remedyrepack | 10 October 2024 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 2 June 1950 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Procainamide
Clinical summary
Procainamide is an antiarrhythmic indicated for the treatment of documented ventricular arrhythmias, such as sustained ventricular tachycardia, that, in the judgement of the physician, are life-threatening. It is available as injection for intramuscular and intravenous use. MedsAcross supplies Procainamide for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about ProcainamideFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Procainamide Hydrochloride prescribing information (Hospira) · U.S. National Library of Medicine, DailyMed
Need Procainamide 1000 mg/10 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.